Clinical trials
Recruiting Polyneuropathies trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 7 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alnylam Pharmaceuticals | 3 |
| Fondazione Don Carlo Gnocchi ETS | 2 |
| AstraZeneca | 1 |
| Eidos Therapeutics, a BridgeBio company | 1 |
| Intellia Therapeutics | 1 |
| Istituto Clinico Humanitas | 1 |
| Masaryk University | 1 |
| Oslo University Hospital | 1 |
| Rigshospitalet, Denmark | 1 |
| Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Polyneuropathies | 21 |
| Amyloidosis | 7 |
| Amyloid Neuropathies, Familial | 5 |
| Amyloidosis, Familial | 4 |
| Amyloid Neuropathies | 3 |
| Alzheimer Disease | 2 |
| Critical Illness | 2 |
| Diabetes Mellitus | 2 |
| Genetic Predisposition to Disease | 2 |
| Heart Diseases | 2 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.